Stony Brook University Hospital
Stony Brook, New York, 11794-8121, United States
Location status: Recruiting
NCT Number: NCT06401564
Use the template below as a guide to write a brief study description in plain language. Tailor the text that appears in brackets and yellow to your research study. To finalize, delete the text in italics.
The goal of this single-arm study is to explore the use of early virtual reality-based rehabilitation as an adjunct to conventional physical/occupational therapy in adult patients with acute ischemic stroke. The main question it aims to answer is:
Feasibility and tolerability of using immersive Virtual Reality technology-based therapy for patients suffering from acute ischemic stroke in an inpatient hospital setting Participants will receive 1 or 2 virtual reality therapy sessions and complete surveys at the end of each session.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Stony Brook, New York, 11794-8121, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each participant will receive one or two 20 minute VR sessions during their admission. Participants are able to pause or discontinue at any time. During each VR session, participants will use the REAL Immersive VR system and be equipped with a VR headset and 6 sensors attached to the torso, waist, and upper extremities. Patient will then undergo various virtual challenges guided by the physical or occupational therapist facilitating movements of the upper extremity, core, head, and neck.
Time frame: After each session up to 5 weeks
The User Satisfaction Evaluation Questionnaire (USEQ) is a 14-item questionnaire evaluating satisfaction on a scale from 1 (not at all) to 5 (severely).
Time frame: After each session up to 5 weeks
An evaluation tool for assessing the subjective severity of simulator sickness symptoms. A 16-item questionnaire evaluating different symptoms on a scale from 0 (not at all) to 4 (severe).
Time frame: After each session up to 5 weeks
Frequency of adverse events such as dizziness, lightheadedness, nausea, headache, falls, fatigue, or other symptoms prompting program termination prior to end of a single 20-minute session
Time frame: Hospital discharge, an average of 7 days
NIHSS is a standardized method that uses a 42-point scale to measure the level of impairment caused by a stroke. The 42-point scale measures several aspects of brain function, including consciousness, vision, sensation, movement, speech, and language (0 = no stroke and 42 = severe stroke).
Time frame: Hospital discharge, an average of 7 days
The mRS incorporates mental as well as physical adaptations to the neurological deficits. It measures independence rather than performance of specific tasks. The mRS includes 15 items and takes approximately six minutes to complete. Scales consists of seven grades, from zero to six, with zero corresponding to no symptoms and six corresponding to death.
Time frame: After each session up to 1 week
Actual time spent using the Virtual Reality (VR) system
Time frame: After each session up to 1 week
Time spent by therapist assisting patient including set-up.
Contact information is provided by the study sponsor or research team.
Christine Pol, PhD
CONTACT
Ruth Reinsel, PhD
CONTACT
Stony Brook University
Other
Improving Functional and Cognitive Outcomes After Ischemic Stroke Using Virtual Reality Based Rehabilitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07367100
Brain Diseases, Cardiovascular Diseases
Edegem, Belgium
View Trial DetailsNCT07345702
Basilar Artery Occlusion, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05032053
Brain Diseases, Cardiovascular Diseases
Ankang, Shaanxi, China
View Trial DetailsNCT07736885
Brain Diseases, Cardiovascular Diseases
Tianjin, Tianjin Municipality, China
View Trial Details